Primary aldosteronism associated with a giant coronary aneurysm after drug-eluting stent implantation

Yasuyuki Shiraishi, Hiroaki Tanaka, Tetsuro Hayashi, Yumiko Inui, Emi Takayama, Yukinori Ikegami, Jun Fuse, Munehisa Sakamoto, Tonghyo Chong, Yukihiko Momiyama

Research output: Contribution to journalArticle

Abstract

Although primary aldosteronism had been recognized to be a treatable type of hypertension, it was recently suggested to be associated with an increased risk of cardiovascular complications. Coronary artery aneurysm is a rare complication after drug-eluting stent (DES) implantation, and a giant coronary aneurysm is very rare. The present case is a 51-year-old, hypertensive patient with primary aldosteronism who developed myocardial infarction, a giant coronary aneurysm after DES implantation, and then cerebral hemorrhage. Our case suggests the excessively high risk for cardiovascular complications in patients with primary aldosteronism.<. Learning objective: Primary aldosteronism had been recognized to be a treatable type of hypertension. However, recent studies suggest that primay aldosteronism is associated with an increased risk of cardiovascular complications rather than essential hypertension. Coronary artery aneurysm is a rare complication after DES implantation. The present case is a patient with primary aldosteronism who developed myocardial infarction, a giant coronary aneurysm after DES implantation, and then cerebral hemorrhage, thus suggesting the excessively high risk for cardiovascular complications in primary aldosteronism.>.

Original languageEnglish
Pages (from-to)e11-e14
JournalJournal of Cardiology Cases
Volume7
Issue number1
DOIs
Publication statusPublished - 2013 Jan 1
Externally publishedYes

Fingerprint

Coronary Aneurysm
Hyperaldosteronism
Drug-Eluting Stents
Cerebral Hemorrhage
Coronary Vessels
Myocardial Infarction
Hypertension

Keywords

  • Coronary artery aneurysm
  • Drug-eluting stent
  • Primary aldosteronism

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Primary aldosteronism associated with a giant coronary aneurysm after drug-eluting stent implantation. / Shiraishi, Yasuyuki; Tanaka, Hiroaki; Hayashi, Tetsuro; Inui, Yumiko; Takayama, Emi; Ikegami, Yukinori; Fuse, Jun; Sakamoto, Munehisa; Chong, Tonghyo; Momiyama, Yukihiko.

In: Journal of Cardiology Cases, Vol. 7, No. 1, 01.01.2013, p. e11-e14.

Research output: Contribution to journalArticle

Shiraishi, Y, Tanaka, H, Hayashi, T, Inui, Y, Takayama, E, Ikegami, Y, Fuse, J, Sakamoto, M, Chong, T & Momiyama, Y 2013, 'Primary aldosteronism associated with a giant coronary aneurysm after drug-eluting stent implantation', Journal of Cardiology Cases, vol. 7, no. 1, pp. e11-e14. https://doi.org/10.1016/j.jccase.2012.09.002
Shiraishi, Yasuyuki ; Tanaka, Hiroaki ; Hayashi, Tetsuro ; Inui, Yumiko ; Takayama, Emi ; Ikegami, Yukinori ; Fuse, Jun ; Sakamoto, Munehisa ; Chong, Tonghyo ; Momiyama, Yukihiko. / Primary aldosteronism associated with a giant coronary aneurysm after drug-eluting stent implantation. In: Journal of Cardiology Cases. 2013 ; Vol. 7, No. 1. pp. e11-e14.
@article{3a38d5409e304390b0b7d7af58b35744,
title = "Primary aldosteronism associated with a giant coronary aneurysm after drug-eluting stent implantation",
abstract = "Although primary aldosteronism had been recognized to be a treatable type of hypertension, it was recently suggested to be associated with an increased risk of cardiovascular complications. Coronary artery aneurysm is a rare complication after drug-eluting stent (DES) implantation, and a giant coronary aneurysm is very rare. The present case is a 51-year-old, hypertensive patient with primary aldosteronism who developed myocardial infarction, a giant coronary aneurysm after DES implantation, and then cerebral hemorrhage. Our case suggests the excessively high risk for cardiovascular complications in patients with primary aldosteronism.<. Learning objective: Primary aldosteronism had been recognized to be a treatable type of hypertension. However, recent studies suggest that primay aldosteronism is associated with an increased risk of cardiovascular complications rather than essential hypertension. Coronary artery aneurysm is a rare complication after DES implantation. The present case is a patient with primary aldosteronism who developed myocardial infarction, a giant coronary aneurysm after DES implantation, and then cerebral hemorrhage, thus suggesting the excessively high risk for cardiovascular complications in primary aldosteronism.>.",
keywords = "Coronary artery aneurysm, Drug-eluting stent, Primary aldosteronism",
author = "Yasuyuki Shiraishi and Hiroaki Tanaka and Tetsuro Hayashi and Yumiko Inui and Emi Takayama and Yukinori Ikegami and Jun Fuse and Munehisa Sakamoto and Tonghyo Chong and Yukihiko Momiyama",
year = "2013",
month = "1",
day = "1",
doi = "10.1016/j.jccase.2012.09.002",
language = "English",
volume = "7",
pages = "e11--e14",
journal = "Journal of Cardiology Cases",
issn = "1878-5409",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Primary aldosteronism associated with a giant coronary aneurysm after drug-eluting stent implantation

AU - Shiraishi, Yasuyuki

AU - Tanaka, Hiroaki

AU - Hayashi, Tetsuro

AU - Inui, Yumiko

AU - Takayama, Emi

AU - Ikegami, Yukinori

AU - Fuse, Jun

AU - Sakamoto, Munehisa

AU - Chong, Tonghyo

AU - Momiyama, Yukihiko

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Although primary aldosteronism had been recognized to be a treatable type of hypertension, it was recently suggested to be associated with an increased risk of cardiovascular complications. Coronary artery aneurysm is a rare complication after drug-eluting stent (DES) implantation, and a giant coronary aneurysm is very rare. The present case is a 51-year-old, hypertensive patient with primary aldosteronism who developed myocardial infarction, a giant coronary aneurysm after DES implantation, and then cerebral hemorrhage. Our case suggests the excessively high risk for cardiovascular complications in patients with primary aldosteronism.<. Learning objective: Primary aldosteronism had been recognized to be a treatable type of hypertension. However, recent studies suggest that primay aldosteronism is associated with an increased risk of cardiovascular complications rather than essential hypertension. Coronary artery aneurysm is a rare complication after DES implantation. The present case is a patient with primary aldosteronism who developed myocardial infarction, a giant coronary aneurysm after DES implantation, and then cerebral hemorrhage, thus suggesting the excessively high risk for cardiovascular complications in primary aldosteronism.>.

AB - Although primary aldosteronism had been recognized to be a treatable type of hypertension, it was recently suggested to be associated with an increased risk of cardiovascular complications. Coronary artery aneurysm is a rare complication after drug-eluting stent (DES) implantation, and a giant coronary aneurysm is very rare. The present case is a 51-year-old, hypertensive patient with primary aldosteronism who developed myocardial infarction, a giant coronary aneurysm after DES implantation, and then cerebral hemorrhage. Our case suggests the excessively high risk for cardiovascular complications in patients with primary aldosteronism.<. Learning objective: Primary aldosteronism had been recognized to be a treatable type of hypertension. However, recent studies suggest that primay aldosteronism is associated with an increased risk of cardiovascular complications rather than essential hypertension. Coronary artery aneurysm is a rare complication after DES implantation. The present case is a patient with primary aldosteronism who developed myocardial infarction, a giant coronary aneurysm after DES implantation, and then cerebral hemorrhage, thus suggesting the excessively high risk for cardiovascular complications in primary aldosteronism.>.

KW - Coronary artery aneurysm

KW - Drug-eluting stent

KW - Primary aldosteronism

UR - http://www.scopus.com/inward/record.url?scp=84872615490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872615490&partnerID=8YFLogxK

U2 - 10.1016/j.jccase.2012.09.002

DO - 10.1016/j.jccase.2012.09.002

M3 - Article

AN - SCOPUS:84872615490

VL - 7

SP - e11-e14

JO - Journal of Cardiology Cases

JF - Journal of Cardiology Cases

SN - 1878-5409

IS - 1

ER -